Sutro Biopharma reported total assets of $194.46M and total liabilities of $297.78M for the quarter ended Jun 2026, down 39.5% year over year. This balance sheet covers 36 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2016 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 56.39M | 30.71M | 30.41M | 28.90M | 79.11M | 96.78M | 47.25M | 62.47M | 235.09M | 81.83M | 69.27M | 65.22M | 90.79M | 174.58M | 190.30M | 106.23M | 64.03M | 65.93M | 58.13M | 54.34M | ||||||||||||||||
| Short-term InvestmentsInvestments (Current) | 167.03M | 159.23M | 130.34M | 142.50M | 112.51M | 190.56M | 255.09M | 188.99M | 123.20M | 239.27M | 264.41M | 202.38M | 284.78M | 213.68M | 126.59M | 142.74M | 141.11M | 101.67M | 83.30M | 110.01M | ||||||||||||||||
| Cash & Current Investments | 223.42M | 189.94M | 160.76M | 171.40M | 191.63M | 287.34M | 302.34M | 251.47M | 358.29M | 321.11M | 333.68M | 267.60M | 375.57M | 388.25M | 316.89M | 248.97M | 205.13M | 167.59M | 141.43M | 164.35M | ||||||||||||||||
| Receivables - NetNet Receivables | 9.16M | 12.33M | 12.45M | 11.69M | 97.67M | 11.24M | 7.12M | 9.87M | 10.00M | 16.63M | 36.08M | 31.30M | 6.95M | 6.66M | 8.62M | 13.56M | 8.00M | 3.92M | 3.98M | 5.80M | ||||||||||||||||
| Receivables - OtherOther Receivables | ||||||||||||||||||||||||||||||||||||
| Receivables | 9.16M | 12.33M | 12.45M | 11.69M | 97.67M | 11.24M | 7.12M | 9.87M | 10.00M | 16.63M | 36.08M | 31.30M | 6.95M | 6.66M | 8.62M | 13.56M | 8.00M | 3.92M | 3.98M | 5.80M | ||||||||||||||||
| Prepaid Assets | 9.75M | 8.70M | 8.12M | 7.91M | 8.20M | 11.06M | 11.67M | 17.70M | 10.34M | 9.48M | 9.85M | 10.06M | 10.53M | 10.87M | 17.80M | 24.88M | 18.50M | 10.60M | 5.52M | 5.50M | ||||||||||||||||
| Current Assets | 277.62M | 250.73M | 218.51M | 228.74M | 331.51M | 346.55M | 353.15M | 304.06M | 411.99M | 381.25M | 421.54M | 354.58M | 443.48M | 405.78M | 343.31M | 287.41M | 231.63M | 182.11M | 150.93M | 175.65M | ||||||||||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 18.67M | 23.32M | 22.55M | 23.29M | 23.60M | 24.28M | 24.62M | 24.03M | 23.64M | 22.34M | 21.94M | 20.63M | 19.41M | 19.00M | 18.19M | 16.80M | 14.98M | 13.35M | 10.65M | 8.36M | ||||||||||||||||
| Long-Term Investments | 60.01M | 64.30M | 68.80M | 20.70M | ||||||||||||||||||||||||||||||||
| Other Non-Current Assets | 0.87M | 0.87M | 0.87M | 0.87M | 0.87M | 0.87M | 0.87M | 0.87M | 0.87M | 0.87M | 3.57M | 0.86M | 0.86M | 0.86M | 7.17M | 0.86M | 0.86M | 0.86M | 0.86M | 1.13M | ||||||||||||||||
| Non-Current Assets | 82.17M | 120.74M | 122.89M | 74.93M | 54.11M | 54.15M | 53.79M | 53.95M | 52.91M | 50.48M | 49.19M | 48.82M | 45.57M | 46.05M | 43.90M | 34.02M | 30.73M | 27.55M | 22.90M | 18.82M | ||||||||||||||||
| Assets | 359.79M | 371.47M | 341.41M | 303.68M | 385.62M | 400.70M | 406.94M | 358.02M | 464.90M | 431.73M | 470.74M | 403.40M | 489.04M | 451.83M | 387.21M | 321.43M | 262.36M | 209.66M | 173.83M | 194.46M | ||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||||||||||
| Accounts Payables | 7.64M | 11.17M | 6.01M | 10.71M | 12.57M | 12.44M | 4.80M | 5.06M | 3.86M | 5.53M | 9.44M | 7.51M | 6.09M | 6.22M | 10.47M | 8.18M | 4.31M | 7.03M | 7.57M | 3.36M | ||||||||||||||||
| Payables | 7.64M | 11.17M | 6.01M | 10.71M | 12.57M | 12.44M | 4.80M | 5.06M | 3.86M | 5.53M | 9.44M | 7.51M | 6.09M | 6.22M | 10.47M | 8.18M | 4.31M | 7.03M | 7.57M | 3.36M | ||||||||||||||||
| Accumulated Expenses | 6.51M | 8.49M | 11.42M | 5.41M | 7.75M | 10.38M | 14.76M | 12.39M | 19.59M | 19.42M | 38.47M | 37.75M | 33.06M | 32.13M | 31.25M | 36.57M | 38.15M | 34.68M | 34.58M | 30.24M | ||||||||||||||||
| Other Accumulated Expenses | 0.72M | 0.30M | 2.75M | 2.79M | 4.15M | 4.41M | 3.08M | 2.19M | 7.33M | 3.04M | 3.90M | 3.41M | 3.58M | 3.46M | 4.01M | 14.17M | 17.83M | 15.79M | 2.91M | 2.73M | ||||||||||||||||
| Short term Debt | 3.12M | 6.25M | 9.38M | 12.50M | 12.50M | 12.50M | 12.50M | 13.24M | 10.20M | 7.14M | 4.06M | |||||||||||||||||||||||||
| Current Leases | 1.45M | 1.04M | 1.08M | 1.12M | 2.63M | 4.58M | 5.25M | 5.93M | 6.17M | 6.42M | 6.67M | 6.93M | 7.20M | 7.48M | 7.76M | 8.06M | 7.96M | 7.78M | 6.66M | |||||||||||||||||
| Current Taxes | 15.16M | 15.16M | 0.01M | 0.02M | 0.02M | |||||||||||||||||||||||||||||||
| Current Deferred Revenue | 8.13M | 7.80M | 5.50M | 6.28M | 6.49M | 15.92M | 16.76M | 17.19M | 18.04M | 23.98M | 20.67M | 20.50M | 73.96M | 72.56M | 69.78M | 68.98M | 11.96M | 8.98M | 10.56M | 6.46M | ||||||||||||||||
| Total Current Liabilities | 26.12M | 35.45M | 41.74M | 38.76M | 44.57M | 58.29M | 66.55M | 59.49M | 67.12M | 73.61M | 93.75M | 79.51M | 129.99M | 131.29M | 131.89M | 133.05M | 74.25M | 71.89M | 75.13M | 52.90M | ||||||||||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||||||||||
| Non-Current Debt | 21.69M | 18.71M | 15.74M | 12.76M | 9.78M | 6.78M | 3.77M | |||||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 3.43M | 0.14M | 90.00M | 74.73M | 89.89M | 85.05M | 79.88M | 78.15M | 53.38M | 46.31M | 21.69M | 18.00M | 12.54M | 8.57M | 6.91M | 3.76M | 2.03M | |||||||||||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||||||||||||
| Operating Leases | 32.07M | 31.22M | 31.63M | 32.07M | 31.04M | 29.57M | 28.07M | 26.53M | 24.86M | 23.15M | 21.40M | 19.59M | 17.66M | 15.67M | 13.63M | 11.54M | 9.70M | 7.89M | 4.12M | |||||||||||||||||
| Other Non-Current Liabilities | 0.84M | 1.50M | 0.15M | 0.15M | 0.14M | 0.13M | 0.12M | 1.69M | 1.69M | 1.69M | 1.69M | 1.69M | 1.69M | 1.69M | 1.69M | 1.69M | 1.69M | |||||||||||||||||||
| Total Non-Current Liabilities | 51.44M | 86.39M | 88.70M | 83.16M | 176.42M | 170.84M | 189.78M | 319.39M | 303.68M | 335.17M | 338.92M | 340.91M | 345.55M | 292.77M | 295.23M | 304.59M | 296.08M | |||||||||||||||||||
| Total Liabilities | 52.29M | 87.89M | 88.84M | 83.30M | 176.56M | 170.97M | 189.90M | 172.60M | 310.18M | 319.39M | 321.09M | 305.38M | 336.87M | 340.61M | 342.61M | 347.24M | 294.47M | 296.93M | 306.28M | 297.78M | ||||||||||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||||||||||
| Total Debt | 24.82M | 24.96M | 25.11M | 25.26M | 22.28M | 19.28M | 16.27M | 13.24M | 10.20M | 7.14M | 4.06M | |||||||||||||||||||||||||
| Common Equity | 307.50M | 283.58M | 252.56M | 220.37M | 209.06M | 229.73M | 217.05M | 185.41M | 154.72M | 112.43M | 149.65M | 98.02M | 152.18M | 111.22M | 44.60M | -25.81M | -32.11M | -87.27M | -132.45M | -103.32M | ||||||||||||||||
| Liabilities and Shareholders Equity | 359.79M | 371.47M | 341.41M | 303.68M | 385.62M | 400.70M | 406.94M | 358.02M | 464.90M | 431.73M | 470.74M | 403.40M | 489.04M | 451.83M | 387.21M | 321.43M | 262.36M | 209.66M | 173.83M | 194.46M | ||||||||||||||||
| Retained Earnings | -264.40M | -295.30M | -333.41M | -372.52M | -398.53M | -418.02M | -452.62M | -502.70M | -541.20M | -590.50M | -559.41M | -617.62M | -665.64M | -714.43M | -786.87M | -862.84M | -874.34M | -931.20M | -977.96M | -1055.00M | ||||||||||||||||
| Treasury Shares |